Evidence map›Paper›PMID 40542788›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Optimizing Chemotherapy Waiting Time in the Day Care Unit for Gastrointestinal Cancer Patients: A Lean Six Sigma Approach.

Muath Dayeh, Balaqis Al Faliti, Ikram Burney, Salim AlDhahli, Mohamed El Kholy, Sara Al Sheedi, Ahmad Al Ghoche, Muna AlBalushi, Ossayed Al Awor, Khader Abukoukash and 13 more

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Muath DayehNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Balaqis Al FalitiQuality and Accreditation Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Ikram BurneyMedical Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Salim AlDhahliNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Mohamed El KholyPharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Sara Al SheediQuality and Accreditation Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Ahmad Al GhocheMedical Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Muna AlBalushiNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Ossayed Al AworLaboratory Service Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Khader AbukoukashNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Wesam IbrahimNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Souad Al MaaloufNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Mohamad MajedNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Abdulaziz AlBadiPharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Rawan IbrahimQuality and Accreditation Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Hamed Al AmriPatient Flow Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Amna Al-HasharPharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Razzan Al ZadjaliQuality and Accreditation Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Huda Al-AwaisiNursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Khalid Al-BaimaniMedical Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Eyad AlMadhounPharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Nasr Al RiyamiPatient Flow Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Omar AyaadQuality and Accreditation Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.ORCID 0000-0003-1521-117X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelays in chemotherapy waiting in a day care unit (DCU) can lead to heightened patient anxiety, and reduced satisfaction, and unnecessary delays for the staff. PURPOSE: This study aimed to optimize chemotherapy initiation times for cancer patients by addressing inefficiencies and enhancing process reliability.

methodsThe study was conducted in a DCU at a dedicated cancer center. Patients attending the gastrointestinal cancer program were selected. A pre-and post-one group design was employed to compare metrics before and after the intervention.  Implementing the Lean Six Sigma (LSS), principles, and using the DMAIC (Define, Measure, Analyze, Improve, Control) approach, we collected baseline data, identified bottlenecks, and implemented targeted solutions. A multidisciplinary team of nursing staff, physicians, and administrators collaborated on the project. The study was approved by the institutional research and ethics committee.

resultsKey interventions included the introduction of fast-track and normal-track pathways based on lab readiness, transitioning from round-based to clinic-based evaluations, optimizing patient and staff workflows, standardizing diagnostic processes, and addressing systemic issues such as network outages and resource shortages. The mean time for chemotherapy waiting decreased from 188.4 minutes to 128 minutes, reflecting a substantial improvement in process efficiency. Variability and outliers were notably reduced, as evidenced by improvements in process capability indices. The Process Potential Index (Pp) increased from 0.76 to 0.86, indicating better overall consistency in the process, while the Process Performance Index (Ppk) rose from -0.05 to 0.52, reflecting improved alignment with specification limits and reduced variability. Additionally, the percentage of cases outside the specification limits dropped significantly from 60.6% to 7.3%, demonstrating enhanced process reliability. The Defects Per Million Opportunities (DPMO) decreased dramatically from 606,060.6 to 72,727.3, highlighting a considerable reduction in defects and inefficiencies.

conclusionImplementing LSS principles successfully reduced chemotherapy waiting times and enhanced process efficiency in the DCU. These findings demonstrate the potential of LSS to address systemic inefficiencies and improve patient-centered outcomes in healthcare. Future efforts should focus on expanding these methodologies to other areas and incorporating advanced technologies to sustain improvements.

Indexed as

Day Care, MedicalGastrointestinal NeoplasmsTime-to-TreatmentTotal Quality ManagementFemaleFollow-Up StudiesHumansPrognosisWaiting Listschemotherapy initiationGastrointestinal cancerLean Six Sigma

Identifiers

PMID40542788
PMCPMC12374506

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.